Allergies and asthma are common conditions that affect millions of people worldwide. They can significantly impact one's quality of life, causing symptoms such as sneezing, itching, wheezing, and shortness of breath. Traditional treatments, such as medications and avoidance measures, can help manage symptoms but may not offer long-term relief. Oral immunotherapy (OIT), a type of allergy immunotherapy, has emerged as a promising therapeutic approach for the management of allergies and asthma. In this article, we will discuss the science behind OIT, its potential benefits, and the latest advancements in this rapidly evolving field.
Oral immunotherapy is a treatment method that involves gradually exposing the immune system to small amounts of an allergen (a substance that causes an allergic reaction) to desensitize the immune system to specific allergens, thereby reducing the severity and frequency of allergic reactions. This can be achieved through the consumption of small amounts of allergenic food (in the case of food allergies) or through the administration of allergen extracts (in the case of respiratory allergies).
The goal of OIT is to induce a state of immune tolerance, wherein the immune system no longer reacts adversely to the allergen. Unlike traditional allergy treatments that focus on managing symptoms, OIT works by modifying the immune response and preventing the development of new allergies. The Food and Drug Administration (FDA) has approved several oral immunotherapy products for specific food allergies, such as peanut, and ongoing studies are exploring its potential for other allergens and asthma.
The science behind OIT is based on the concept of immune modulation. The immune system is a complex network of cells and molecules that work together to protect the body against infectious agents and other harmful substances. In individuals with allergies, the immune system mistakenly identifies certain allergens as threats and mounts an exaggerated response, leading to the release of inflammatory mediators and the manifestation of allergic symptoms.
OIT seeks to "retrain" the immune system by promoting the production of regulatory T cells (Treg cells) and the release of anti-inflammatory cytokines, such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β). These changes help to suppress the exaggerated immune response and ultimately reduce the severity and frequency of allergic reactions.
Oral immunotherapy offers several advantages over traditional allergy treatments, including:
1. Long-Term Relief: OIT has been shown to provide lasting relief from allergies, even after the treatment is stopped. Studies have demonstrated that patients who undergo oral immunotherapy can experience a significant reduction in symptoms, with some even achieving complete remission.
2. Improved Quality of Life: Allergies can severely impact a person's daily life and well-being, leading to anxiety, social isolation, and decreased productivity. OIT can help alleviate these burdens by reducing symptoms and the need for avoidance measures, allowing individuals to enjoy a more unrestricted lifestyle.
3. Prevention of New Allergies: Research suggests that oral immunotherapy may have a protective effect against the development of new allergies. This is especially important for young children, who are at a higher risk of developing multiple allergies and asthma.
4. Customizable Treatment: Oral immunotherapy can be tailored to a patient's specific allergen profile and severity, offering a personalized approach to allergy management.
5. Non-Invasive Delivery: Unlike allergy shots, which require frequent visits to a healthcare provider for injections, oral immunotherapy can be administered at home, making it more convenient and accessible for patients.
While oral immunotherapy offers significant potential benefits for allergy sufferers, there are also several potential risks to consider:
1. Allergic Reactions: The most significant risk associated with OIT is the potential for allergic reactions, which can range from mild to life-threatening. These reactions can occur during treatment or after ingestion of the allergen outside of the controlled setting of OIT.
2. Side Effects: In addition to allergic reactions, OIT can cause side effects such as gastrointestinal symptoms, including abdominal pain, nausea, and vomiting.
3. Treatment Duration: OIT requires a significant time commitment, with patients needing to take small doses of the allergen daily for several months or even years. This can be challenging for some patients and may impact their compliance with the treatment.
4. Cost: OIT can be expensive, with some insurance companies not covering the treatment. This can make it difficult for some patients to access this type of therapy.
5. Uncertainty of Long-Term Outcomes: While OIT has been found to be effective in reducing allergy symptoms in the short term, there is still uncertainty about the long-term outcomes of the treatment, including the potential for relapse after discontinuing therapy.
As the field of oral immunotherapy continues to evolve, researchers are exploring new strategies and technologies to improve its safety, efficacy, and accessibility. Some of these advancements include:
Traditionally, OIT has been administered for single allergens, such as peanuts or milk. However, recent studies have shown promising results for multi-allergen oral immunotherapy, where patients are simultaneously desensitized to multiple allergens. This approach could be especially beneficial for individuals with multiple food allergies or a combination of asthma and allergies.
Scientists are investigating the use of biomarkers (biological indicators) to predict a patient's response to oral immunotherapy and guide treatment decisions. By identifying specific immune system markers, healthcare providers can better determine which patients are likely to respond positively to OIT and tailor treatment plans accordingly. This approach has the potential to improve the effectiveness of OIT and reduce the risk of adverse reactions. Additionally, biomarker-guided therapy may help identify patients who are not good candidates for OIT, allowing healthcare providers to explore alternative treatment options.
In 2020, the US Food and Drug Administration (FDA) approved the first OIT product for peanut allergy, known as Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp]. Update: Palforzia was withdrawn from the US market on July 31, 2026, by its manufacturer for commercial rather than safety reasons; peanut oral immunotherapy now continues off-label at specialist centers. This particular oral immunotherapy (OIT) product is standardized and tailored to individuals who have peanut allergies. Its primary aim is to reduce the impact of allergic reactions, which can include anaphylaxis, that may occur due to accidental exposure to peanuts. OIT is designed for patients aged 4 to 17 years old who have received a confirmed diagnosis of peanut allergy.
Researchers are working to develop personalized dosing strategies for OIT based on individual patient characteristics, such as age, allergen sensitivity, and immune system profile. This approach aims to optimize treatment outcomes by tailoring the treatment protocol to the needs of each patient. For example, younger patients may require lower doses of the allergen to reduce the risk of adverse reactions, while patients with severe allergies may require a slower dose escalation to ensure safety.
Personalized dosing strategies may also involve varying the frequency or duration of treatment based on the patient's response to the therapy. This approach has the potential to improve the safety and effectiveness of OIT, as well as reduce the duration and cost of treatment by minimizing unnecessary exposure to allergens.
Oral immunotherapy (OIT) is a promising therapeutic approach for the management of allergies and asthma. By gradually exposing the immune system to small amounts of an allergen, OIT aims to desensitize the body and reduce allergic reactions. While OIT comes with potential risks, including allergic reactions and treatment duration, it also offers significant benefits such as long-term relief, improved quality of life, and prevention of new allergies. With ongoing research and advancements in OIT, the future looks bright for millions of people suffering from allergies and asthma.
If you are someone who suffers from allergies or asthma and is interested in exploring oral immunotherapy for allergies as a treatment option, then Curex is your best option. We are a leading Online Allergy Clinic that offers custom solutions to desensitize your body from allergies. We specialize in long-term effective allergy, asthma, sinusitis and eczema treatments. Trusted with more than 50,000 users, we provide convenient treatments and immunotherapy services right in the comfort of your own home. Don't let allergies and asthma hold you back any longer—take the first step towards relief with Curex! Take our Free Allergy Quiz today to get started!
